Publication date: December 2026 Source: Journal of Diabetes and its Complications, Volume 40, Issue 12 Author(s): Mona S. Abdel Monem, Ahmed M. Kamel, Maggie M. Abbassi, Nirmeen A. Sabry
SGLT2 inhibitors in diabetic biopsy proven MASH patients: A systematic review and meta-analysis. // Journal of Diabetes and its Complications. – URL: https://www.sciencedirect.com/science/article/pii/S1056872726001820?dgcid=rss_sd_all
SGLT2 inhibitors in diabetic biopsy proven MASH patients: A systematic review and meta-analysis. Journal of Diabetes and its Complications. https://www.sciencedirect.com/science/article/pii/S1056872726001820?dgcid=rss_sd_all
“SGLT2 inhibitors in diabetic biopsy proven MASH patients: A systematic review and meta-analysis.” Journal of Diabetes and its Complications.
@article{article53159,
title = {SGLT2 inhibitors in diabetic biopsy proven MASH patients: A systematic review and meta-analysis},
journal = {Journal of Diabetes and its Complications},
url = {https://www.sciencedirect.com/science/article/pii/S1056872726001820?dgcid=rss_sd_all}
}
Abstract Background Macrophage polarisation plays a crucial role in sepsis‐associated inflammatory responses; however, the underlying molecular regulatory mechanisms remain to be further explored. Aim This study aimed to explore the...